Ezetimibe and the risk of new-onset type 2 diabetes: a systematic review and meta-analysis
Ann Med. 2025 Dec;57(1):2594355. doi: 10.1080/07853890.2025.2594355. Epub 2025 Nov 30.ABSTRACTBACKGROUND: Statins reduce cardiovascular risk but may increase new-onset type 2 diabetes mellitus (NO-T2DM). Ezetimibe, a cholesterol absorption inhibitor, is often added to statins to improve lipid contro

